Efficacy and safety of mono antiplatelet therapy with colchicine in acute coronary syndrome patients following percutaneous coronary intervention: rationale and design of the MACT II trial

IntroductionEarly discontinuation of aspirin after percutaneous coronary intervention (PCI) reduces bleeding risk, while inflammation-targeted strategies may offer additional benefit in patients with acute coronary syndrome (ACS). Residual inflammatory risk—reflected by persistently elevated high-se...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Frontiers in Cardiovascular Medicine
المؤلفون الرئيسيون:	Ji Yong Jang, Yongsung Suh, Choongki Kim, Jeong Tae Byoun, Kyeong Ho Yun, Jung-Hee Lee, Ki-Hyun Jeon, Sungsoo Cho, Hyuk-Joon Yoon, Jin Won Kim, Bom Lee, Se Hun Kang, Sang-Hoon Kim, Jae Youn Moon, Yangsoo Jang, Seung-Yul Lee
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Frontiers Media S.A. 2025-10-01
الموضوعات:	acute coronary syndrome percutaneous coronary intervention aspirin colchicine ticagrelor
الوصول للمادة أونلاين:	https://www.frontiersin.org/articles/10.3389/fcvm.2025.1662392/full